1. Introduction {#sec1-ijerph-16-01440}
===============

Carbon tetrachloride (CCl~4~) is a classical hepatotoxicant model that is often studied for xenobiotic-induced oxidative hepatotoxicity \[[@B1-ijerph-16-01440]\]. Bio-activation of the hepatic cytochrome P~450~ system catabolizes CCl~4~ to trichloromethyl radical (CCl~3~^−^), which is a highly reactive metabolite. This CCl~3~^−^ radical further reacts with oxygen to form the most toxic reactive trichloromethyl peroxy radical, which can bind to macromolecules. This leads to cell membrane disruption and cell death \[[@B2-ijerph-16-01440]\]. Oxidative stress arises when there is an imbalance between production and scavenging of reactive oxygen species (ROS). The major cause for various degenerative diseases including some hepatopathies is oxidative stress \[[@B3-ijerph-16-01440]\]. Natural antioxidants are considered to be effective and safe alternative treatments for hepatotoxicity in comparison to synthetic antioxidants, which may be carcinogenic \[[@B4-ijerph-16-01440],[@B5-ijerph-16-01440]\].

Worldwide, about 60% of the population uses traditional medicines. During the last few decades, there has been a remarkable development in the field of herbal medicine \[[@B6-ijerph-16-01440]\]. *Ammannia baccifera* Linn. (Family: Lythraceae) is being used as traditional medicine in India and China. It has a wide range of therapeutic and pharmacological properties, including antiurolithiasis, antibacterial, central nervous system (CNS) anti-depressant, antifungal, antitumor, anti-inflammatory, and antisteroidogenic activities \[[@B7-ijerph-16-01440],[@B8-ijerph-16-01440],[@B9-ijerph-16-01440]\]. Our earlier in vitro study described the antioxidant potential of the ethanolic extract of *Ammannia baccifera* (EEAB) \[[@B10-ijerph-16-01440]\]. Most of the available reports on the beneficial effects of *A. baccifera* extract showed that secondary metabolites of its extract, which are of a phenolic nature, are responsible for the array of biological activities. No clear molecular mechanism of action has been revealed to date.

Ultra-high performance liquid chromatography (UHPLC) with mass spectrometry (MS), which facilitates rapid separation and identification of components of the plant extracts \[[@B11-ijerph-16-01440]\], has been widely used for metabolic profiling. The use of high resolution mass spectrometry (HRMS) further improves sensitivity and selectivity, which has aided concurrent identification of numerous known and unknown metabolites \[[@B12-ijerph-16-01440]\]. Despite *Ammannia baccifera* having long been used as traditional medicine in India and China, there is no detailed information on the antioxidant activity of this herbal plant in vivo. Therefore, it is useful to examine the hepatoprotective effects of EEAB in rats after CCl~4~ stress. The isoenzyme composition and gene expression of enzymes---CuZn-SOD, CAT, and GPx of liver were also studied, along with chemical characterization of EEAB through ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS).

2. Materials and Methods {#sec2-ijerph-16-01440}
========================

2.1. Plant Material {#sec2dot1-ijerph-16-01440}
-------------------

Whole herbs of *Ammannia baccifera* were procured from the local areas of Tirumala Tirupati Hills, Andhra Pradesh, India. The herb was identified and authenticated by the Botanist, Dr. K. Madhava Chetty, Sri Venkateswara University, India.

2.2. Preparation of A. baccifera Extract {#sec2dot2-ijerph-16-01440}
----------------------------------------

The whole herbs of *A. baccifera* (15--20 plants) were shade dried and powdered using a blender (Hammer Mill) and 100 g of this powder was soaked in 500 mL ethanol (95%) for a week in dark conditions and at room temperature (26--28 °C). After a week, the extract was concentrated after filtration in a rotary evaporator and stored at −20 °C. The yield of the extract was 8.6% (\~9 g from 100 g of dried powder).

2.3. Phytochemical Analysis by UHPLC-QTOF-MS {#sec2dot3-ijerph-16-01440}
--------------------------------------------

Analyses were done in an Agilent 1290 UHPLC system (Agilent Technologies Inc., Palo Alto, CA) comprising a 1260 infinity Nano HPLC with Chipcube, 6550 iFunnel Q-TOFs. Full scans from *m*/*z* 50--1000 @ 1.2 scans/s were collected. A Rapid Resolution HD column -Zorbax SB C-18 with 2.1 mm × 100 mm × 1.8µm dimensions was used at 35 °C with a flow rate of 0.4 mL/min and an injection volume of 20 µL. The other conditions used: Ionization: Heated Electrospray (HESI). Transfer line temperature: 350 °C. Spray voltage: 4 kV. Nebulizing gas: Nitrogen generated by Peak Scientific NM32LA model nitrogen generator. Analysis in a positive mode was carried out in a gradient mobile phase with binary solvents containing water with 0.1% formic acid as mobile phase A and Methanol with 0.1% formic acid as mobile phase B. The mobile phase B varied from 0--95% from 0--50 min, 95% B from 50--55 min, and initial conditions from 55.1--60 min. A similar program was used in a negative ionization mode with mobile phase A, as water and mobile phase B, as acetonitrile. The maximal tolerated *m*/*z* deviation was set to 10 ppm \[[@B13-ijerph-16-01440]\]. The molecular formulas of compounds were identified by HRMS by comparing theoretical and observed mass. Compounds were identified by comparing the mass values with the existing databases like the knapsack family databases, Metlin, and Lipidmaps that were identified from Mass Hunter Qualitative analysis software (version B.06.00) Agilent Technologies, Santa Clara, CA, USA.

2.4. Animals {#sec2dot4-ijerph-16-01440}
------------

Male rats (Albino Wistar, 200 to 250 g) were purchased from the local supplier and acclimatized for one week prior to experimentation. They had free access to a pelleted diet (Hindustan Lever Ltd., Mumbai, India) and water *ad libitum* at 25 ± 2 °C with a 12-h light/dark cycle. Female rats were excluded in this study to avoid the data variability caused by hormonal cycles in females. All the procedures were in accordance with the Institutional regulations, controlled by the committee CPCSEA of Ministry of Social Justice and Empowerment of India. Approved by the Institutional Animal Ethics Committee \[(Regd.No. 438/01/a/CPCSEA/dt 17.7.2001) in its resolution number 9/IAEC/ SVU/ Zool, dated 4.3.2002\].

2.5. Experimental Procedure {#sec2dot5-ijerph-16-01440}
---------------------------

According to previous acute toxicological reports of EEAB, 2000 mg/kg body weight of EEAB was proven to be nontoxic to rats \[[@B14-ijerph-16-01440]\]. Earlier sub-acute studies that used four different doses of EEAB (50, 100, 250, and 500 mg/Kg body weight) to determine the dose-dependent effects in rats revealed no signs of toxicity \[[@B14-ijerph-16-01440]\]. Hence, we chose the 250 and 500 mg/kg doses of EEAB in the present study.

Animals were randomly assigned into four groups of six rats in each experimental group and EEAB dissolved in distilled water was administered daily via intra-gastric intubation. Group I: control − olive oil (1 mL/kg)Group II: toxic control − 30% CCl~4~Group III: EEAB 250 mg/kg + 30% CCl~4~Group IV: EEAB 500 mg/kg + 30% CCl~4~

Excluding the control (Group I), all animals in Groups II, III, and IV received 30% CCl~4~ olive oil (1 mL/Kg) via intraperitoneal injection for one time every three days for an eight-week period \[[@B15-ijerph-16-01440]\]. Animals in Groups III and IV, respectively, received 250 mg/kg and 500 mg/kg EEAB, 72 h prior to CCl~4~ treatment.

After eight weeks, experimental rats were anesthetized and sacrificed by cervical dislocation, and the liver samples were collected, rinsed with saline solution, and stored at −80 °C. Samples were homogenized as described earlier \[[@B16-ijerph-16-01440]\]. The protein was measured by the Bradford \[[@B17-ijerph-16-01440]\] method.

2.6. Quantification of Lipid Peroxidation (LPO) and Analysis of Lipids {#sec2dot6-ijerph-16-01440}
----------------------------------------------------------------------

Lipid Peroxidation (LPO) was measured by using malondialdehyde (MDA) as the standard, where thiobarbituric acid reacts with MDA forming a pink colored complex, due to peroxidation of lipids, which is measured at 532 nm \[[@B18-ijerph-16-01440]\]. Chloroform-methanol mixture (2:1 *v*/*v*) \[[@B19-ijerph-16-01440]\] was used for extraction of lipids from liver tissue to measure the amount of total cholesterol \[[@B20-ijerph-16-01440]\], triacylglycerides \[[@B21-ijerph-16-01440],[@B22-ijerph-16-01440]\], and phospholipids \[[@B23-ijerph-16-01440]\].

The cholesterol content was measured using FeCl~3~-uranyl acetate and H~2~SO~4~-FeSO~4~ as reagents. After 20 min of incubation, the purple color developed was read at 540 nm. For triacylglyceride measurement, chloroform-methanol mixture (2:1) and activated silicic acid was added to the lipid extract for phospholipid absorption followed by saponification and incubation with sulphuric acid, sodium meta periodate, and chromotropic acid. After incubation, thiourea solution was added to the final contents and the absorbance was read at 570 nm. Phospholipids were measured using the acid digestion process using perchloric acid and the absorbance was measured at 710 nm, after the addition of ascorbic acid and ammonium molybdate.

2.7. Analysis of Protein Damage: Estimation of Protein Carbonyl and Total Sulfhydryl (Thiol) Contents {#sec2dot7-ijerph-16-01440}
-----------------------------------------------------------------------------------------------------

The protein carbonyl content of liver homogenates was measured using 2,4-Dinitrophenylhydrazine, which is measured at 370 nm \[[@B24-ijerph-16-01440]\]. Briefly, 100 µL of sample was incubated with 100 µL of DNPH (100 mM) and the protein was precipitated with 20% TCA. The resultant pellet was dissolved in 6 µM guanidine hydrochloride (pH 6.5), after washing with ethyl acetate:ethanol (1:1 *v*/*v*).

Estimation of total sulphydryl content was based on 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) reaction, where DTNB is reduced by the thiol group to form 1 mole of 2-nitro-5-mercaptobenzoic acid per mole-SH that was read at 412 nm \[[@B25-ijerph-16-01440]\].

2.8. Antioxidants {#sec2dot8-ijerph-16-01440}
-----------------

Standard methods were used for estimating the Superoxide dismutase (SOD), Catalase (CAT), and Glutathione peroxidase (GPx), as described in the earlier study \[[@B16-ijerph-16-01440]\]. SOD was quantified according to the method based on the oxidation of epinephrine transition by the enzyme to form an adenochrome, which was measured at 470 nm (1 unit of SOD = Enzyme required to inhibit 50% of epinephrine auto-oxidation) \[[@B26-ijerph-16-01440]\]. Quantification of CAT activity was measured based on the decomposition of H~2~O~2~ by the enzyme and the decrease in absorbance at 240 nm was used to determine the activity (μmol of H~2~O~2~ consumed/min/mg protein) \[[@B27-ijerph-16-01440]\]. GPx activity was determined by continuous monitoring of NADPH oxidation in the reaction of cumene hydroperoxide decomposition \[[@B28-ijerph-16-01440]\].

The non-enzymatic antioxidants, such as reduced glutathione (GSH), vitamin C, and vitamin E were assessed by the standard methods. GSH was determined by the reaction with 5,5′-dithiobis-2 nitrobenzoic acid, which forms a yellow-colored complex and was read at 412 nm \[[@B29-ijerph-16-01440]\]. Vitamin C was analyzed by the oxidative reaction with copper to form dehydroascorbic acid, which reacts with 2,4-dinitrophenyl hydrazine to produce a product with an absorption maximum at 520 nm \[[@B30-ijerph-16-01440]\]. Vitamin E was quantified based on the Emmeric---Engel reaction \[[@B31-ijerph-16-01440]\].

2.9. Separation and Quantification of Isozyme Response by Electrophoresis {#sec2dot9-ijerph-16-01440}
-------------------------------------------------------------------------

Following the standard method \[[@B32-ijerph-16-01440]\], gel electrophoresis with non-denaturing polyacrylamide was performed and the SOD, CAT, and GPx activity staining methods were followed, as described earlier \[[@B16-ijerph-16-01440]\]. The SOD isozymes were determined by soaking the gel in a 50-mm Tris-HCl buffer reagent comprised of nitro-blue tetrazolium (NBT), ethylene diamine tetra acetic acid, and riboflavin and incubated in dark for 30 min. CAT isozymes were detected by soaking the gel for 10 min in a 5-mm H~2~O~2~ solution, rinsed using double distilled water, and then stained with a reaction mixture containing 1% of ferric chloride and potassium ferricyanide (*w*/*v*). GPx isozymes were detected by immersing the gel in 50-mm Tris-HCl buffer containing NBT and phenazine methosulphate. Densitometric scanning of stained gels was performed to quantify the band areas of isozymes.

2.10. RNA Extraction and Quantification by a Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) {#sec2dot10-ijerph-16-01440}
-----------------------------------------------------------------------------------------------------

Total RNA was extracted following a prescribed kit protocol \[[@B33-ijerph-16-01440]\], and gene expression (SOD, CAT and GPX) was measured using the RT-PCR method, as previously described \[[@B16-ijerph-16-01440]\]. The thermal cycler (Eppendorf Mastercycler ep gradient S, motorized lid, 200--240 V) was used to complete the RT-PCR reaction under the following conditions. One reverse transcription step for 30 min at 50 °C. The initial enzyme activation step of 15 min at 95 °C. An amplification step for 30 cycles. The initial denaturation step for 30 s at 94 °C. An annealing step for 30 s at 58 °C and an extension step for 1 min at 72 °C \[[@B34-ijerph-16-01440]\]. The gene-specific primers used are presented in [Table 1](#ijerph-16-01440-t001){ref-type="table"}. The RT-PCR product (10 µL) was resolved on agarose gel (2%) to compare the quantity of steady state mRNA. Each target gene expression was standardized with β-actin (internal control gene) and represented as a ratio.

2.11. Statistical Analysis {#sec2dot11-ijerph-16-01440}
--------------------------

The analysis was carried out using one-way Analysis of Variance (ANOVA), which was followed by the Duncan's Multiple Range Test (DMRT). The data was tested for normality and homoscedascity using the SPSS software. Statistical Package for Social Sciences (SPSS) 15.0 (IBM Corporation, Chicago, IL, USA) was used for analysis and the *p*-value was set at *p* \< 0.05. Data are presented as means ± SEs.

3. Results {#sec3-ijerph-16-01440}
==========

3.1. Identification of Metabolites by UHPLC-QTOF-MS {#sec3dot1-ijerph-16-01440}
---------------------------------------------------

The total chromatogram for the positive ion is presented in [Figure S1](#app1-ijerph-16-01440){ref-type="app"}. The results show that the positive ion chromatogram yielded significantly higher signals. In the negative mode, none of the compounds were identified (data not presented). The putative identities of 16 are identified in a positive mode and are summarized in [Table 2](#ijerph-16-01440-t002){ref-type="table"}. The compounds identified are hydroxycinnamic acids, flavonoids, terpenoids, and fatty acids. The major compounds include chlorogenic acid, quercetin, pentahydroxy flavanone, cosmosiin, dihydromyricetin, and protocatechuic acid, and terpenoids including lamioside, crocetin, and khayasin C.

3.2. Lipid Peroxidation and Lipid Profile {#sec3dot2-ijerph-16-01440}
-----------------------------------------

The hepatic LPO levels including cholesterol, triacylglycerides, and phospholipids are presented in [Table 3](#ijerph-16-01440-t003){ref-type="table"}. A marked rise in hepatic MDA, cholesterol, and triacylglycerides was noticed in CCl~4~-treated rats. Hepatic LPO, cholesterol, and triacylglycerides levels returned to normal after treatment with ethanolic extract of *A. baccifera* (EEAB). CCl~4~ decreased the hepatic phospholipid levels considerably, which were restored towards the control level by using EEAB.

3.3. Total Protein, Protein Carbonyl, and Total Sulfhydryl Content {#sec3dot3-ijerph-16-01440}
------------------------------------------------------------------

Total protein levels were significantly depleted in CCl~4~-intoxicated rats. Treatment with EEAB at two doses significantly increased the protein content of liver tissue, when compared to rats treated with CCl~4~ alone ([Table 4](#ijerph-16-01440-t004){ref-type="table"}). The hepatic protein carbonyl levels were considerably augmented in CCl~4~ exposed rats. Administration of EEAB caused a substantial reduction (*p* \< 0.01) in the levels of protein carbonyls of the liver tissue when compared to rats treated with CCl~4~ alone ([Table 4](#ijerph-16-01440-t004){ref-type="table"}).

The levels of total sulfhydryl groups are presented in [Table 4](#ijerph-16-01440-t004){ref-type="table"}. CCl~4~-intoxicated rats (Group II) showed a significant reduction in the levels of hepatic total sulfhydryl's in comparison to the control (Group I). These variations were restored toward normal levels in both groups (Group III and Group IV) of EEAB-treated rats ([Table 4](#ijerph-16-01440-t004){ref-type="table"}).

3.4. Spectrophotometric Analysis of Antioxidants {#sec3dot4-ijerph-16-01440}
------------------------------------------------

The hepatic antioxidant and non-enzymatic antioxidants are shown in [Table 5](#ijerph-16-01440-t005){ref-type="table"}. Significant depletion of all the studied antioxidants was observed in liver tissues of CCl~4~-treated rats. The levels of all these enzymatic and non-enzymatic antioxidants were re-established toward control levels after treatment with EEAB.

3.5. Expression of Antioxidant Enzyme Proteins {#sec3dot5-ijerph-16-01440}
----------------------------------------------

Electrophoretic densitometric patterns of SOD, CAT, and GPx isozymes in all four treatment groups are represented in [Figure 1](#ijerph-16-01440-f001){ref-type="fig"}A,B. Two isozymes of SOD (SOD1 and SOD2) were observed in the liver tissue ([Figure 1](#ijerph-16-01440-f001){ref-type="fig"}A). The zymogram shows that the differences in band areas of isozyme SOD1 were basically comparable in all the groups while the SOD2 isoform showed decreased staining intensity in the CCl~4~ group, in contrast with the control. The staining intensity was more intense for SOD~2~ in EEAB-treated Group IV, in comparison to EEAB-treated Group III and CCl4-intoxicated Group II ([Figure 1](#ijerph-16-01440-f001){ref-type="fig"}A,B).

The CAT isozyme activity staining zymogram is shown in [Figure 1](#ijerph-16-01440-f001){ref-type="fig"}A. The CAT isozyme electrophoretic pattern showed a single band with minor changes in the band area. The staining intensity and band area of the CAT isozyme was significantly reduced in CCl~4~-intoxicated rats, in comparison with the control. EEAB treatment at two doses displayed a substantial increase in the staining intensity and band area of the CAT isozyme, compared to CCl~4~-intoxicated rats ([Figure 1](#ijerph-16-01440-f001){ref-type="fig"}B).

[Figure 1](#ijerph-16-01440-f001){ref-type="fig"}A depicts the GPx isozymes and the activity-staining zymogram. GPx activity bands revealed four isozymes: GPx1, GPx2, GPx3, and GPx4. Isozymes GPx1 and GPx4 were considered to be bands that were principally comparable in all the groups ([Figure 1](#ijerph-16-01440-f001){ref-type="fig"}B). However, a noticeable diminution in the band areas of the enzymes GPx2 and GPx3 was seen in the group treated with CCl~4~ (Group II), in contrast with the control (Group I). EEAB treatment (Group III and IV) revealed enhanced band areas for the isoenzymes GPx2 and GPx3 in comparison with the Group II rats intoxicated with CCl~4~.

3.6. Antioxidant Enzymes: mRNA Expression {#sec3dot6-ijerph-16-01440}
-----------------------------------------

To further confirm the observed changes in the spectral analysis and isozyme pattern of antioxidant enzymes, RT-PCR was used to examine the relative gene expression profiles of antioxidants in the liver with primers that are gene specific, as shown in [Table 1](#ijerph-16-01440-t001){ref-type="table"}. For confirming the enzymatic antioxidant alterations at the gene transcription level with the EEAB treatment, the measurement of the ratio of SOD/catalase/GPx mRNA to β-actin mRNA was done. The electrophoretic profile of the RT-PCR products of SOD, CAT, and GPx along with the housekeeping gene (β-actin) is represented in [Figure 2](#ijerph-16-01440-f002){ref-type="fig"}A. The relative mRNA expression levels of CAT (32%), GPx (36.5%), and SOD (37%) antioxidant genes were noticeably downregulated in the CCl~4~-intoxicated group ([Figure 2](#ijerph-16-01440-f002){ref-type="fig"}B). Notable upregulation in SOD (43%, 52.3%), CAT (44.4%, 61.4%), and GPx (35.3%, 51%) mRNA levels were observed in both the doses of EEAB-treated groups correspondingly, compared to Group II rats intoxicated with CCl~4~.

4. Discussion {#sec4-ijerph-16-01440}
=============

CCl~4~, which is a strong hepatotoxic agent, has been widely used to establish animal models for screening the hepatoprotective activities of drugs \[[@B16-ijerph-16-01440],[@B35-ijerph-16-01440]\]. Oxidative stress plays a vital role in CCl~4~-induced toxicity. CCl~4~ is converted to a trichloromethyl-free radical by cytochrome P~450~, which begins a series of free radical reactions leading to an increase in LPO. This disturbs the membrane integrity and Ca^2+^ homeostasis to produce hepatocellular damage \[[@B36-ijerph-16-01440]\]. The use of phytochemicals with antioxidant activity can offer protection against the oxidative damage \[[@B37-ijerph-16-01440]\]. The present investigation revealed that an ethanolic extract of *A. baccifera* (EEAB) significantly attenuated the CCl~4~ induced oxidative stress by augmenting the endogenous antioxidant levels.

Although qualitative screening of *A. baccifera* chemical compounds has been reported earlier using different analytical techniques \[[@B38-ijerph-16-01440]\], in this study, we used UHPLC-QTOF-MS, which significantly facilitates the simultaneous detection of compounds in lower amounts \[[@B39-ijerph-16-01440]\]. The major phytochemicals identified in the present study include chlorogenic acid, quercetin, pentahydroxy flavanone, cosmosiin, dihydromyricetin, protocatechuic acid, lamioside, crocetin, and khayasin, which belong to the group of polyphenolic compounds. The antioxidant and hepatoprotective activity of EEAB may be credited to the presence of these phytochemicals. Flavonoids and polyphenolic compounds are well-known natural antioxidants and these compounds counteract oxidative stress by direct ROS scavenging activity, metal chelation, and induction of antioxidant enzymes as well as phase II detoxifying enzymes \[[@B40-ijerph-16-01440]\]. Hepato-protective and antioxidant activities of chlorogenic acid, quercetin, cosmosiin, and protocatechuic acid have been well recognized \[[@B41-ijerph-16-01440],[@B42-ijerph-16-01440],[@B43-ijerph-16-01440],[@B44-ijerph-16-01440]\]. Dihydromyricetin is a natural antioxidant and a potent depigment agent \[[@B45-ijerph-16-01440]\].

The mechanism of CCl~4~-induced liver injury is the stimulation of LPO and generation of ROS, which was reported earlier \[[@B36-ijerph-16-01440]\]. In this study, significantly higher MDA, an end-product of membrane LPO, was observed in CCl~4~-treated rats indicating hepatic damage with a concomitant decrease in antioxidant levels. Treatment with EEAB prevented the oxidative damage by reducing LPO and restoring the antioxidant levels when compared to the control. This could be attributed to the existence of radical scavenging antioxidant chemical constituents, as identified from UHPLC-QTOF-MS. Augmentation of lipids is considered to be a pathological state, which is an indication of impaired liver function under chronic accumulation \[[@B46-ijerph-16-01440]\]. An increased cholesterol and triacylglycerides level was observed after CCl~4~ intoxication. Earlier studies showed that the CCl~4~ causes the synthesis of cholesterol to rise in hepatocytes \[[@B2-ijerph-16-01440]\]. Decreased levels of phospholipids were observed after CCl~4~ treatment, which could be due to an augmentation in phospholipase activity \[[@B47-ijerph-16-01440],[@B48-ijerph-16-01440]\], as phospholipase causes the cell membrane damage degrading membrane phospholipids \[[@B48-ijerph-16-01440]\]. Furthermore, these phospholipids are more vulnerable to CCl~4~-induced LPO than other lipid classes \[[@B49-ijerph-16-01440]\] and play a central role in the transport of triacylglycerides. During regular lipoprotein metabolism, phospholipids are broadly converted into triacylglycerides \[[@B50-ijerph-16-01440]\] (Wiggins and Gibbons, 1996). Furthermore, EEAB treatment normalized all the abnormal parameters due to CCl~4~ intoxication to near control levels. The present results are in accordance with previous studies related to lipid profiles after curcumin treatment against CCl~4~ toxicity \[[@B51-ijerph-16-01440]\].

CCl~4~ caused a significant augmentation in protein carbonyl contents and decreased total sulfhydryl levels. This is an indication of protein damage and increased levels of protein carbonyls causing changes in protein conformations, which leads to enhanced aggregation, fragmentation, distortion of secondary and tertiary structure, and vulnerability to proteolysis and diminution of normal function \[[@B52-ijerph-16-01440]\]. Thus, conservation of the protein redox status is vital for cell function. Any modifications in protein structure may lead to hepatotoxicity at the molecular level. Our present findings are in accordance with other studies showing an increased level of protein carbonyl contents after CCl~4~ treatment \[[@B53-ijerph-16-01440]\]. Co-treatment with EEAB reduced the protein carbonyl contents and restored the sulfhydryl levels toward the level of the control group.

Reduced Glutathione (GSH) is the key non-enzymatic antioxidant that regulates the intracellular redox homeostasis, which is ubiquitously present in all cell types to protect from deleterious effects of ROS \[[@B54-ijerph-16-01440]\]. CCl~4~ significantly reduced the GSH levels. The reestablished GSH levels, after EEAB treatment, could be due to regeneration and synthesis of GSH. The increased GSH levels can protect the liver from oxidative damage by directly scavenging the ROS, or being a component of the GSH redox system, which includes GPx, glutathione reductase, and glutathione-s-transferase (GST) \[[@B55-ijerph-16-01440]\]. Furthermore, we found a marked decrease in vitamin C and vitamin E after CCl~4~ treatment, which were recovered by EEAB treatment. These findings are in good agreement with the earlier studies \[[@B56-ijerph-16-01440]\]. The increased level of vitamin C and vitamin E in EEAB-treated rats reveals the anti-oxidative nature of the plant extract. The extract may scavenge the free radicals and, thus, maintain the normal level of vitamin C and vitamin E. It is well established that GSH in blood keeps up the cellular levels of the active forms of vitamin C and vitamin E by neutralizing the free radicals. When there is a reduction in the GSH content, the cellular levels of vitamin C are also lowered, which indicates that GSH, vitamin C, and vitamin E are closely interlinked to each other \[[@B57-ijerph-16-01440]\]. Reduction in cellular GSH levels is correlated to vitamin C, which indicates that all the antioxidants are closely interlinked \[[@B57-ijerph-16-01440]\].

Among the antioxidants, the three main enzymes CAT, GPx, and SOD are the first line of protection against oxidative stress \[[@B58-ijerph-16-01440]\]. SOD converts the superoxide anion to H~2~O~2~ and O~2~. Furthermore, H~2~O~2~ reduction is catalyzed by CAT and GPx, which guards the tissue against biomolecule-damaging ROS \[[@B59-ijerph-16-01440]\]. GST is a Phase 2 enzyme, which has a vital function in detoxification of the xenobiotics by converting it into more hydrophilic compounds in conjugation with GSH \[[@B60-ijerph-16-01440],[@B61-ijerph-16-01440]\]. CCl~4~ triggered a marked reduction in the antioxidant enzymes SOD, CAT, and GPx and their levels were returned to near control values after EEAB treatment. The in vitro and in vivo antioxidant activity, including the free radical scavenging activity of EEAB, was reported earlier \[[@B10-ijerph-16-01440],[@B25-ijerph-16-01440]\].

Alterations in gene expression after chronic toxicant exposure have a major influence on disease advancement \[[@B62-ijerph-16-01440]\]. Microarray studies have revealed that CCl~4~ causes gene expression changes, which provides a molecular response to CCl~4~ toxicity \[[@B63-ijerph-16-01440]\]. Our studies show that the gene expression levels of SOD, CAT, and GPx were down regulated after CCl~4~ treatment, and these results are in good accordance with other studies \[[@B16-ijerph-16-01440],[@B64-ijerph-16-01440]\]. Depletion of antioxidant enzymes during CCl~4~ toxicity not only causes oxidative stress, but also causes impairment of enzymatic structure and function \[[@B16-ijerph-16-01440],[@B65-ijerph-16-01440]\]. Furthermore, EEAB treatment considerably augmented the gene expression levels of all the studied antioxidants. Previous studies have revealed that polyphenols, such as hyperin, rotenone, and other plants extracts containing quercetin and rutin, significantly induce the gene expression of SOD, CAT, and GPx \[[@B16-ijerph-16-01440],[@B64-ijerph-16-01440],[@B66-ijerph-16-01440]\]. It has also been reported that the exogenous antioxidants during oxidative damage may promote the synthesis of antioxidant enzymes and, thereby, result in increased mRNA expression levels \[[@B67-ijerph-16-01440]\]. The present findings are in accordance with the earlier studies \[[@B16-ijerph-16-01440],[@B67-ijerph-16-01440]\]. The alterations in isoform profiles (SOD1, CAT, GPx2, and GPx3) detected in the current study after oxidative stress induced by CCl~4~ can be related to alterations in the gene expression. These alterations in the isoforms pattern during stress have been ascribed to the changes in gene expression \[[@B68-ijerph-16-01440]\]. In this study, the discrepancy between gene expression and enzyme activity seen in the case of CCl~4~ induced stress may be due to the toxic effect of CCl~4~ being more pronounced at the post-transcriptional modification levels than at the post-translation modification levels. Furthermore, the complex regulation of gene expression mechanisms cannot be precisely associated with enzyme activity. However, the overall trend of antioxidant enzymes and gene expression during CCl~4~ stress conditions were in good agreement.

5. Conclusions {#sec5-ijerph-16-01440}
==============

The present study demonstrates that EEAB confers protection against CCl~4~-induced oxidative stress mainly by augmenting the endogenous antioxidant levels and scavenging free radicals. Moreover, significant variations in isozyme profiles and down regulation of the gene expression of CAT, GPx, and SOD after CCl~4~ treatment were normalized after EEAB treatment. The phenolic and flavonoid compounds in EEAB identified using UHPLC-QTOF-MS may be responsible for its antioxidant and hepatoprotective activity. Additional studies are desirable on the active molecule isolation from EEAB to be used as a novel hepatoprotective agent.
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The following are available online at <https://www.mdpi.com/1660-4601/16/8/1440/s1>, Figure S1: Total chromatogram of Ammania baccifera ethanol extract in ESI positive mode by using UHPLC-QTOF MS.
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![Effect of EEAB on mRNA expression of antioxidant enzymes in the liver of CCl~4~-treated rats. (**A**) RT-PCR profile. (**B**) Histogram of relative transcript levels. Treatments---I: control. II: CCl~4~ 30%. III: EEAB (250 mg/kg) + CCl~4~ 30%. IV: EEAB (500 mg/kg) + CCl~4~ 30%. Values are mean ± SEM (*n* = 3). Means with different suffix letters (a, b and c) differ significantly (*p* \< 0.05).](ijerph-16-01440-g002){#ijerph-16-01440-f002}
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###### 

Primer sequences used for the analysis of gene expression.

  Gene Description   Primer Sequence (5′→3′)          Gene Bank Accession No.   Length (bp)
  ------------------ -------------------------------- ------------------------- -------------
  Cu-Zn-SOD          F: 5′GCAGAAGGCAAGCGGTGAAC        X05634                    387
                     R: 5′TAGCAGGACAGCAGATGAGT                                  
  CAT                F: 5′GCGAATGGAGAGGCAGTGTAC       AH004967                  670
                     R:5′GAGTGACGTTGTCTTCATTAGCACTG                             
  GPx                F: 5′CTCTCCGCGGTGGCACAGT         M21210                    290
                     R: 5′CCACCACCGGGTCGGACATAC                                 
  B-Actin \*         F: 5′CTGCTTGCTGATCCACA           V01217                    505
                     R: 5′CTGACCGAGCGTGGCTAC                                    

**\*** Housekeeping gene. F: Forward, R: Reverse.
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###### 

Phenolics and other compounds were identified in *Ammannia baccifera* ethanol extract by using UHPLC-QTOF-MS.

  S. No.                      RT (min)                 Mass       Tentative Identification   Formula           DB Diff (ppm)
  --------------------------- ------------------------ ---------- -------------------------- ----------------- ------------------------
  **Hydroxycinnamic Acids**                                                                                    
  1                           4.37                     354.0958   Chlorogenic acid           C~16~H~18~O~9~    −2.09
  Flavonoids                                                                                                   
  2                           4.67; 6.65               448.0992   Quercetin                  C~21~H~20~O~11~   2.96; 4.08
  3                           4.67; 6.43; 6.65; 9.16   304.0578   Pentahydroxy flavanone     C~15~H~12~O~7~    1.73; 2.58; 3.28; 3.29
  4                           6.05                     432.1052   Cosmosiin                  C~21~H~20~O~10~   1.1
  5                           6.02; 6.22;              320.0527   Dihydromyricetin           C~15~H~12~O~8~    1.75; 3.31
  6                           5.03                     344.086    Eupatorin                  C~18~H~16~O~7~    10.49
  7                           6.72                     317.065    Petunidin                  C~16~H~13~O~7~    3.71
  8                           0.82                     138.0675   4-Hydroxyphenyl ethanol    C~8~H~10~O~2~     4.38
  9                           6.78                     154.026    Protocatechuic acid        C~7~H~6~O~4~      3.65
  Terpenoids                                                                                                   
  10                          4.56; 4.79               420.1618   Lamioside                  C~18~H~28~O~11~   3.26; 1.41
  11                          14.7; 18.06              328.1665   Crocetin                   C~20~H~24~O~4~    2.83; 2.38
  12                          4.07; 4.17               526.2536   Khayasin C                 C~30~H~38~O~8~    5.75; 6.42
  13                          4.90                     166.099    Perillic acid              C~10~H~14~O~2~    2.03
  14                          6.61                     150.1038   (-)-Isopiperitenone        C~10~H~14~O       4.16
  15                          4.66                     406.1458   10-Hydroxyloganin          C~17~H~26~O~11~   4.11
  16                          4.9                      152.1197   (-)-trans-Carveol          C~10~H~16~O       2.88
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###### 

Effect of EEAB on lipid peroxidation (LPO) and lipid profiles in liver tissue of rats intoxicated with CCl~4~.

  Parameter           Group I            Group II           Group III           Group IV            *p*-Value
  ------------------- ------------------ ------------------ ------------------- ------------------- -----------
  LPO                 1.83 ± 0.01 ^a^    3.94 ± 0.01 ^b^    3.08 ± 0.01 ^b,c^   2.15 ± 0.02 ^a^     0.041
  Triacylglycerides   3.21 ± 0.01 ^a^    6.57 ± 0.05 ^b^    4.82 ± 0.04 ^c^     3.79 ± 0.02 ^a,c^   0.010
  Cholesterol         3.10 ± 0.04 ^a^    4.22 ± 0.05 ^b^    4.02 ± 0.02 ^c^     3.72 ± 0.02 ^a^     0.010
  Phospholipids       14.11 ± 0.03 ^a^   10.16 ± 0.05 ^b^   12.75 ± 0.16 ^c^    13.85± 0.04 ^a^     0.045

Treatments---I: control. II: CCl~4~ 30%. III: EEAB (250 mg/kg) + CCl~4~ 30%. IV: EEAB (500 mg/kg) + CCl~4~ 30%. LPO: nmoles of MDA/mg protein. Triacylglycerides, cholesterol, and phospholipids: mg/g tissue wt. Values are mean ± SEM (*n* = 3). Means with different suffix letters (a, b, c and d) differ significantly (*p* \< 0.05).
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###### 

Effect of EEAB on protein damage (protein carbonyl and protein sulfhydryl) in liver tissue of rats intoxicated with CCl~4~.

  Parameter          Group I             Group II           Group III           Group IV            *p*-Value
  ------------------ ------------------- ------------------ ------------------- ------------------- -----------
  Total Protein      154.23 ± 0.54 ^a^   128.9 ± 0.32 ^b^   135.92 ± 0.45 ^c^   147.95 ± 0.39 ^a^   0.006
  Protein Carbonyl   3.91 ± 0.01 ^c^     21.47 ± 0.17 ^a^   17.94 ± 0.15 ^d^    7.50 ± 0.22 ^a^     0.045
  Total Sulfhydryl   3.10 ± 0.021 ^a^    0.91 ± 0.02 ^b^    1.53 ± 0.01 ^c^     2.87 ± 0.02 ^a^     0.030

Treatments---I: control. II: CCl~4~ 30%. III: EEAB (250 mg/kg) + CCl~4~ 30%. IV: EEAB (500 mg/kg) + CCl~4~ 30%. Total protein: mg/dL. Protein carbonyls: *n* moles/mg protein. Total sulfhydryl: mmoles/mg protein. Values are mean ± SEM (*n* = 3). Means with different suffix letters differ (a, b, c and d) significantly (*p* \< 0.05).
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###### 

Effect of EEAB on enzymatic and non-enzymatic antioxidants in liver of rats intoxicated with CCl~4~.

  Parameter   Group I            Group II           Group III          Group IV           *p*-Value
  ----------- ------------------ ------------------ ------------------ ------------------ -----------
  SOD         0.54 ± 0.01 ^a^    0.19 ± 0.00 ^b^    0.34 ± 0.00 ^c^    0.46 ± 0.00 ^d^    0.000
  CAT         78.27 ± 0.57 ^a^   32.73 ± 0.16 ^b^   48.68 ± 0.16 ^c^   68.77 ± 0.27 ^d^   0.030
  GPx         60.77 ± 0.80 ^a^   27.57 ± 0.64 ^b^   40.86 ± 0.28 ^c^   55.89 ± 0.29 ^c^   0.007
  GSH         5.61 ± 0.15 ^a^    1.29 ± 0.02 ^b^    2.92 ± 0.02 ^c^    4.73 ± 0.15 ^d^    0.033
  Vitamin C   3.10 ± 0.02 ^a^    2.14 ± 0.06 ^b^    2.56 ± 0.03 ^c^    2.81 ± 0.01 ^c^    0.014
  Vitamin E   1.81 ± 0.01 ^a^    0.89 ± 0.02 ^b^    1.13 ± 0.03 ^c^    1.55 ± 0.02 ^d^    0.035

Treatments---I: control. II: CCl~4~ 30%. III: EEAB (250 mg/kg) + CCl~4~ 30%. IV: EEAB (500 mg/kg) + CCl~4~ 30%. CAT: µmoles of H~2~O~2~ utilized/min/mg protein. SOD: units/min/mg protein. GPX: µmoles of GSH oxidized/min/mg protein. GSH: µg of GSH/mg protein. Vitamin C & E: µg/mg protein. Values are mean ± SEM (*n* = 3). Means with different suffix letters (a, b, c and d) differ significantly (*p* \< 0.05).
